Live Analyst Rating Changes 24623 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Elizabeth Anderson CFA
EVR

Elizabeth Anderson CFA

Evercore ISI
Wall Street Analyst
★★★★★
#260
on 13Foresight · ranked by our own returns
70%
Success Rate
+10.7%
Average Return
39 of 56 calls profitable · +6.4% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 70% of Elizabeth Anderson CFA's ratings turned a profit when each position was held for 1 year — averaging +10.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

144 Buy 49 Hold 0 Sell
Elizabeth's Stock Coverage 29 ratings · 2026-08-14
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
GMRS
GMR Solutions, Inc. Class A
 Aug 13, 2026 BUY Strong Buy
+44.8% avg upside
9 analysts
$20.00
43.29% Upside
 · ·
COR
Cencora
 Aug 13, 2026 BUY Buy
+3.7% avg upside
44 analysts
$350.00
12.84% Upside
 · ·
IQV
IQVIA Holdings
 Aug 12, 2026 BUY Strong Buy
+1.5% avg upside
39 analysts
$275.00
13.91% Upside
 -1.8% ·
CAH
Cardinal Health
 Aug 12, 2026 BUY Strong Buy
-9.9% avg upside
29 analysts
$270.00
16.74% Upside
 -1.1% ·
ALGN
Align Tech
 Aug 10, 2026 BUY Strong Buy
+69.0% avg upside
21 analysts
$220.00
24.84% Upside
 +2.7% ·
DOCS
Doximity
 Aug 07, 2026 HOLD Buy
+29.7% avg upside
28 analysts
$40.00
50.53% Upside
 -3.0% ·
OMDA
Omada Health, Inc.
 Aug 07, 2026 BUY Strong Buy
+9.2% avg upside
12 analysts
$25.00
2.68% Upside
 +1.9% ·
XRAY
DENTSPLY SIRONA
 Aug 07, 2026 HOLD Buy
+149.2% avg upside
25 analysts
$14.00
20.87% Upside
 -4.2% ·
CRL
Charles River Labs
 Aug 06, 2026 BUY Strong Buy
-16.6% avg upside
35 analysts
$300.00
6.59% Upside
 +4.8% ·
CVS
CVS Health
 Aug 06, 2026 BUY Strong Buy
+11.5% avg upside
39 analysts
$125.00
31.56% Upside
 +0.3% ·
MCK
McKesson
 Aug 06, 2026 BUY Strong Buy
-11.0% avg upside
28 analysts
$1000.00
16.81% Upside
 -1.7% ·
NVST
Envista Holdings
 Aug 06, 2026 BUY Buy
+9.1% avg upside
19 analysts
$32.00
14.04% Upside
 +3.4% ·
AGL
Agilon Health
 Aug 06, 2026 HOLD Buy
-24.9% avg upside
26 analysts
$125.00
40.61% Upside
 +7.0% ·
PRVA
Privia Health Group
 Aug 06, 2026 BUY Strong Buy
+47.1% avg upside
26 analysts
$32.00
47.14% Upside
 +0.1% ·
MDLN
Medline
 Aug 06, 2026 BUY Strong Buy
+31.8% avg upside
27 analysts
$39.00
9.56% Upside
 +3.1% ·
HSIC
Henry Schein
 Aug 04, 2026 BUY Buy
+0.6% avg upside
25 analysts
$100.00
10.95% Upside
 +0.1% ·
HNGE
Hinge Health, Inc. Class A
 Aug 04, 2026 BUY Strong Buy
+8.8% avg upside
17 analysts
$100.00
14.46% Upside
 +11.3% ·
WAY
Waystar Holding Corp.
 Jul 30, 2026 BUY Strong Buy
+48.1% avg upside
30 analysts
$28.00
11.72% Upside
 +18.2% ·
ICLR
Icon
 Jul 30, 2026 BUY Strong Buy
+12.5% avg upside
26 analysts
$220.00
31.41% Upside
 -1.6% ·
FTRE
Fortrea Holdings Inc.
 Jul 30, 2026 BUY Buy
+17.5% avg upside
12 analysts
$25.00
40.25% Upside
 -7.3% ·
TDOC
Teladoc
 Jul 30, 2026 HOLD Buy
+315.9% avg upside
38 analysts
$7.50
7.70% Upside
 +3.6% ·
HUM
Humana
 Jul 29, 2026 BUY Buy
+9.4% avg upside
34 analysts
$480.00
24.71% Upside
 +5.3% ·
ELV
Elevance Health
 May 19, 2026 BUY Strong Buy
+13.3% avg upside
33 analysts
$360.00
9.61% Downside
 +0.3% ·
UNH
UnitedHealth
 May 12, 2026 BUY Strong Buy
+14.1% avg upside
36 analysts
$400.00
0.17% Upside
 +1.2% ·
LH
Labcorp Holdings
 May 01, 2026 BUY Strong Buy
-15.9% avg upside
37 analysts
$300.00
7.07% Downside
 +26.4% ·
DGX
Quest Diagnostics
 Apr 20, 2026 HOLD Buy
-22.3% avg upside
34 analysts
$210.00
10.97% Downside
 +21.6% ·
HCAT
Health Catalyst
 Mar 30, 2026 HOLD Buy
+218.0% avg upside
15 analysts
$3.00
71.41% Upside
 +59.3% ·
EHTH
Ehealth
 Aug 09, 2022 HOLD Hold
+1206.8% avg upside
19 analysts
$8.50
602.40% Upside
 +18.9% ·
SLQT
SelectQuote
 May 06, 2022 HOLD Buy
+973.0% avg upside
16 analysts
$3.00
320.16% Upside
 -47.7% ·
🔒 24 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Elizabeth Anderson CFA — Frequently Asked Questions
How accurate are Elizabeth Anderson CFA's stock ratings?
Based on the calls 13Foresight could measure, about 66% of Elizabeth's ratings were profitable over a one-year hold, with an average return of +10.7% per rating, or +6.7% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Elizabeth ranked on 13Foresight?
Elizabeth Anderson CFA is currently ranked #260 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Elizabeth cover?
Elizabeth most recently has ratings on GMRS, COR, IQV, CAH, ALGN, DOCS, OMDA, XRAY, CRL, CVS, MCK, NVST and 17 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.